Evidence map›Paper›PMID 19277872›Full record

ArticleThe AAPS journal2009

Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.

Chenchen Wang, Pavan Muttil, Dongmei Lu, Adela Ayulia Beltran-Torres, Lucila Garcia-Contreras, Anthony J Hickey

Open access · bronzeAbstract read
In one paragraph

Article in The AAPS journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Peptide/protein vaccine delivery system based on PLGA particles.Human vaccines & immunotherapeutics · 2016
    Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Chenchen WangEshelman School of Pharmacy, University of North Carolina at Chapel Hill, Kerr Hall, Campus Box #7360, Room #1310, Chapel Hill, North Carolina 27599, USA.
Pavan Muttil
Dongmei Lu
Adela Ayulia Beltran-Torres
Lucila Garcia-Contreras
Anthony J Hickey
University of North Carolina at Chapel Hill · USSynergy Pharmaceuticals (United States) · USUniversidad Autónoma del Estado de Morelos · MX

Funding

MECHANISMS OF RESPONSE TO PULMONARY VACCINATIONR01HL067221 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI HICKEY, ANTHONY JAMES · 2002 to 2005
$1.0M
NHLBI NIH HHS HL 67221NHLBI NIH HHS R01 HL067221
6 · The paper itself

Abstract

Tuberculosis (TB) infects one third of the world's population, and new infections occur at a rate of 1/s. Better vaccines are needed than the live mycobacterium Bacille Calmette-Guérin (BCG). Alveolar macrophages (AMPhis) play a central role in pulmonary manifestations of TB. Targeting immunomodulators to AMPhis, the first line of defense against Mycobacterium tuberculosis (Mtb), may initiate a potent cell-mediated immune response. Muramyl dipeptide (MDP) and trehalose dibehenate (TDB) have elicited strong immune response when delivered to the lungs as aerosols. AMPhis show toxicity in response to some immunomodulators. The objective of this work was to screen the immunomodulators MDP and/or TDB encapsulated in microparticles (MPs) and to evaluate certain indicators of toxicity in human AMPhi-like cells. Poly(lactide-co-glycolide) (PLGA) MPs containing MDP and/or TDB were prepared by spray-drying. The morphology, particle size distribution, and immunomodulator encapsulation efficiency of MPs were examined. THP-1 cells were exposed to these MPs for 24 h and characteristics of cell morphology, tumor necrosis factor-alpha (TNF-alpha) release, lactate dehydrogenase (LDH), N-acetyl-beta-D: -glucosaminidase (NAG) and alkaline phosphatase (ALP) activity in AMPhi culture supernatants were measured. MTT assay was used to assess the viability of cells. Spray-drying produced low-density MPs having volume median diameters between 4 and 6 microm as measured by laser diffraction and projected area diameter between 3 and 5 microm calculated by microscopy. More TNF-alpha was produced by THP-1 cells exposed to MPs composed of PLGA-MDP or PLGA alone than PLGA-TDB. LDH release following exposure to MPs of PLGA-MDP and PLGA alone was greater than controls. NAG release was higher following exposure to MPs of PLGA alone or PLGA-MDP 0.1% than PLGA-TDB (0.1% and 1.0%). Cells remained viable after exposure to MPs as per MTT assay. PLGA-MDP MPs demonstrated statistically elevated indicators of biochemical responses in cell culture compared to PLGA-TDB MPs, but the extent of their potential to elicit adverse effects in vivo must be studied independently.

Indexed as

Acetylmuramyl-Alanyl-IsoglutamineAdjuvants, ImmunologicAnimalsCell LineCell SurvivalDrug CompoundingDrug DiscoveryHumansLactic AcidMacrophage ActivationMacrophages, AlveolarMiceMicroscopy, Electron, ScanningMonocytesParticle SizePolyglycolic AcidAcetylmuramyl-Alanyl-IsoglutamineAdjuvants, ImmunologicLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerTrehaloseTuberculosis Vaccines

Identifiers

PMID19277872
PMCPMC2664889
OpenAlexW2095745176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.